Results 211 to 220 of about 2,394,296 (251)

Thymoma arising within a unilocular thymic cyst during follow-up: a report of a resected case. [PDF]

open access: yesInt J Surg Case Rep
Maeda R   +5 more
europepmc   +1 more source

Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer

open access: yesMedComm, Volume 7, Issue 10, October 2026.
Mesothelin overexpression activate important pathways like nuclear factor k‐light‐chain‐enhancer of activated B cells (NF‐κB) and interleukin‐6 (IL‐6). This in turn causes numerous cancers, such as pancreatic and ovarian cancers. MSLN‐targeting immunotherapies, like monoclonal antibodies, have shown efficacy.
Manoj Kumar Gupta   +2 more
wiley   +1 more source

Cancer Cell Metastasis: From Molecular Mechanisms to Therapeutic Strategies

open access: yesMedComm, Volume 7, Issue 10, October 2026.
The schematic representation of intrinsic and extrinsic influences of cancer cell metastasis. Genomic evolution of metastatic tumor cells (MTCs) promotes their metastatic phenotypes and reconstruct the primary tumor microenvironment. During MTCs migration along different routes (blood circulation, lymphatic vessels, and perineuronal spaces), the ...
Yupeng Zhao   +7 more
wiley   +1 more source

Myasthenia Gravis and Thymoma

open access: yesMuscle &Nerve, Volume 74, Issue 4, Page 1156-1173, October 2026.
ABSTRACT Thymoma is the most common tumor of the anterior mediastinum. Approximately 20%–30% of patients with a thymoma develop myasthenia gravis (MG), and an additional one third may possess positive acetylcholine receptor (AChR) antibodies without MG.
Benjamin Claytor   +5 more
wiley   +1 more source

Congenital Lung Malformations in Neonates: A 9‐Year Tunisian Cohort Highlighting Diagnostic Challenges and Outcomes in a Resource‐Limited Setting

open access: yesPediatric Pulmonology, Volume 61, Issue 10, October 2026.
ABSTRACT Background Congenital lung malformations (CLMs) represent a broad spectrum of developmental anomalies with highly variable prenatal and postnatal presentations and outcomes. Their postnatal management remains non‐standardized. This study aimed to describe the spectrum of bronchopulmonary malformations diagnosed in the neonatal period, assess ...
Hajer Chourou   +8 more
wiley   +1 more source

Long‐Term Survival Following Nivolumab Treatment in Pulmonary Tumour Thrombotic Microangiopathy Associated With Cancer of Unknown Primary: A Case Report

open access: yesRespirology Case Reports, Volume 14, Issue 10, October 2026.
Pulmonary tumour thrombotic microangiopathy (PTTM) is a rapidly fatal condition that is rarely diagnosed during life. Early clinical recognition and prompt nivolumab treatment resulted in long‐term survival in a patient with cancer of unknown primary‐associated PTTM.
Kosuke Fujishima   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy